Phase III Study of FFI-1010 in Pediatric Kidney Disease

Condition:   Children Under 18 Years Old With Kidney Disease Intervention:   Drug: FFI-1010 Sponsor:   Fuji Yakuhin Co., Ltd. Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials